Last reviewed · How we verify

lactobacillus LS

Ain Shams University · Phase 3 active Small molecule

Lactobacillus LS is a probiotic strain that modulates the gut microbiota and enhances intestinal barrier function and immune response.

Lactobacillus LS is a probiotic strain that modulates the gut microbiota and enhances intestinal barrier function and immune response. Used for Gastrointestinal disorders (specific indication in Phase 3 trial not publicly detailed).

At a glance

Generic namelactobacillus LS
SponsorAin Shams University
Drug classLive biotherapeutic product / Probiotic
ModalitySmall molecule
Therapeutic areaGastroenterology / Immunology
PhasePhase 3

Mechanism of action

This live biotherapeutic product works by colonizing the gastrointestinal tract, producing beneficial metabolites, and promoting the growth of commensal bacteria while inhibiting pathogenic organisms. It strengthens the intestinal epithelial barrier through tight junction protein expression and stimulates local and systemic immune responses via pattern recognition receptors on intestinal immune cells.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: